Dyne Therapeutics (DYN) PT Lowered to $45 at Morgan Stanley
Tweet
Share
E-mailGet Alerts DYN Hot Sheet
Price: $26.10 +0.46%
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Morgan Stanley analyst Michael E Ulz lowered the price target on Dyne Therapeutics (NASDAQ: DYN) to $45.00 (from $47.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
- Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Advance Auto Parts (AAP) PT Lowered to $55 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
